CRON

Michael Ryan Gorenstein

Known title: See remarks belowCIK: 0001797199

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 15, 2026

Cronos completes acquisition of CanAdelaar, expands European presence. Cronos Group announced the completion of its acquisition of CanAdelaar, the largest adult‑use cannabis company in Europe. The deal adds a significant European footprint to Cronos’ operations and may enhance its product distribution across the region. Around the same time, Zuanic & Associates initiated coverage of Cronos with an Overweight rating, indicating a favorable view from the analyst. The stock is currently trading near its $2.72 support level with a mid‑range RSI, suggesting modest momentum.

this person other insiders at CRON

Transaction History

CRON▲ Buy$0
CRON▼ Sell$319K
CRON▼ Sell$340K
CRON▲ Buy$0
CRON▲ Buy$0
CRON▼ Sell$331K
CRON▲ Buy$0
CRON▼ Sell$213K

We use analytics to understand how market-wall is used. No personal data is sold.